Alder BioPharma (ALDR) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts ALDR Hot Sheet
Join SI Premium – FREE
Alder BioPharma (NASDAQ: ALDR) reported Q2 EPS of ($0.79), $0.04 worse than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37
- Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
